CMC-544 (inotuzumab ozogamicin): A CD22-targeted immunoconjugate of calicheamicin
暂无分享,去创建一个
K. Khandke | Dylan W Evans | H. Ross | Damle Nk | Dijoseph Jf | Dougher Mm | Armellino Dc
暂无分享,去创建一个
K. Khandke | Dylan W Evans | H. Ross | Damle Nk | Dijoseph Jf | Dougher Mm | Armellino Dc